Insecticides (India) formalises Q4 results and board changes
The company filed its audited financial statements and confirmed leadership changes, though all figures and appointments were previously disclosed.
— 4 earlier stories on Insecticides (India) Ltd. →What's new
- The board formalised the FY2026 audited results and an employee stock purchase scheme.
- Mrs. Nikunj Aggarwal resigned from the board, with Mr. Sanskar Aggarwal appointed as her successor.
- Revenue for the period stands at ₹2,140 cr.
Why this matters
This filing is a procedural formality. All financial results and leadership transitions were already public, leaving no new information for the market to digest.
What we're watching
- The implementation timeline for the new employee stock purchase scheme.
- Any further shifts in the promoter group leadership.
- Operational performance in the coming quarters.
The full read
Insecticides (India) Ltd. has submitted its audited financial statements for Q4 and FY2026. The filing confirms a revenue of ₹2,140 crore and a net profit of ₹139 crore. Alongside the financials, the company formalised an employee stock purchase scheme and confirmed a leadership transition within the promoter group, with Mr. Sanskar Aggarwal replacing Mrs. Nikunj Aggarwal on the board. These details were already disclosed in earlier filings on the same date. This submission is a routine administrative step. It contains no new price-sensitive information or surprises for investors. The company has simply completed the formal documentation process for its year-end results.
Questions answered
- Does this filing contain new financial information?
- No. The revenue of ₹2,140 crore and net profit of ₹139 crore were already disclosed in earlier filings.
- What leadership changes were confirmed?
- Mrs. Nikunj Aggarwal resigned from the board, and Mr. Sanskar Aggarwal was appointed to the position.
- What is the status of the employee stock purchase scheme?
- The board formalised the scheme as part of its Q4 and FY2026 board meeting outcomes.
- Why is this filing considered routine?
- The document serves as a formal submission of audited statements and board decisions that were already communicated to the market on the same day.
Story so far
All notes on INSECTICID →- 29 May 2026 · 3:24 PM IST Insecticides (India) formalises Q4 results and board changes
- 2d ago Insecticides (India) reports 19% revenue growth for Q4
- 2d ago Insecticides (India) targets 70% premium product mix by FY30
- 2d ago Insecticides (India) revenue climbs 7% as profit dips slightly
- 2d ago Insecticides (India) profit dips as promoter family reshuffles board